In a first, FTC appoints monitor in reverse-payment settlement with Endo

The following article first appeared on July 12 on MLex. For more information on MLex, including getting access to its exclusive content, please contact The Federal Trade Commission appointed a monitor Tuesday to oversee a 10-year consent decree with Endo Pharmaceuticals, the first time the agency has